Budesonide and Formoterol Fumarate Metered Dose Inhaler
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Budesonide and Formoterol Fumarate Metered Dose Inhaler, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS) [Phase 3]